Develop new benchmarks for outcome in pediatric patients with systemic or CNS vasculitis within 3 yrs [clinicaltrials_resource:ed4f11b9c80f4912c9d631f93863bcb1]
Specific and generic disease assessment tools will be used to analyze our registry cohorts to enable the first-ever benchmarks of outcome in children with GPA or PACNS who have had a minimum of 12 months follow up.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Develop new benchmarks for outcome in pediatric patients with systemic or CNS vasculitis within 3 yrs [clinicaltrials_resource:ed4f11b9c80f4912c9d631f93863bcb1]
Specific and generic disease assessment tools will be used to analyze our registry cohorts to enable the first-ever benchmarks of outcome in children with GPA or PACNS who have had a minimum of 12 months follow up.
Bio2RDF identifier
ed4f11b9c80f4912c9d631f93863bcb1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ed4f11b9c80f4912c9d631f93863bcb1
measure [clinicaltrials_vocabulary:measure]
Develop new benchmarks for outcome in pediatric patients with systemic or CNS vasculitis
time frame [clinicaltrials_vocabulary:time-frame]
within 3 yrs
description
Specific and generic disease a ...... inimum of 12 months follow up.
identifier
clinicaltrials_resource:ed4f11b9c80f4912c9d631f93863bcb1
title
Develop new benchmarks for out ...... or CNS vasculitis within 3 yrs
@en
type
label
Develop new benchmarks for out ...... f11b9c80f4912c9d631f93863bcb1]
@en